Experimental proof of contamination of blood components by (1→3)-β-D-glucan caused by filtration with cellulose filters in the manufacturing process

Journal of Artificial Organs

Volumn 6, Issue 1, 2003, Pages 49-54

  Nagasawa, Koichi ^a   Yano, Tatsuyuki ^a   Kitabayashi, Go ^a   Morimoto, Hiroaki ^a   Yamada, Yuji ^a   Ohata, Atsushi ^b   Usami, Makoto ^b   Horiuchi, Takashi ^a  

^a UNIVERSITY OF EAST ASIA   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

(1 3) D glucan; Blood components; Cellulose; Fungal infection; Human serum albumin

Indexed keywords

ALBUMIN; BETA 1,3 GLUCAN; CELLULOSE; NYLON;

ARTICLE; BLOOD COMPONENT; BLOOD FILTRATION; CONTAMINATION; FUNGAL CELL; GOOD MANUFACTURING PRACTICE; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROCESS MODEL; QUALITY CONTROL; SAFETY;

BETA-GLUCANS; BLOOD CHEMICAL ANALYSIS; CELLULOSE; FALSE POSITIVE REACTIONS; FILTRATION; GLUCANS; HUMANS; MANUFACTURED MATERIALS; MEMBRANES, ARTIFICIAL; MYCOSES;

EID: 0037657824     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100470300008     Document Type: Article

References (33)

1. Usui T, Iwasaki Y, Hayashi K, Mizuno T, Tanaka M, Shinkai K, Arakawa M. Antitumor activity of water-soluble β-D-glucan elaborated by Ganoderma applanatum. Agric Biol Chem 1981;45:323-326
2. Usui T, Iwasaki Y, Mizuno T, Tanaka M, Shinkai K, Arakawa M. Isolation and characterization of antitumor active β-D-glucans from the fruit bodies of Ganoderma applanatum. Carbohydrate Res 1983;115:273-280
3. Mizuno T, Ohsawa K, Hagiwara N, Kuboyama R. Fractionation and characterization of antitumor polysaccharides from Maitake, Grifola frondsa. Agric Biol Chem 1986;50:1679-1688
4. Mizuno T, Ando M, Sugie R, Ito H, Shimura K, Sumiya T, Matsuura A. Antitumor activity of some polysaccharides isolated from an edible mushroom, Ningyotake, the fruiting body and the cultured mycelium of Polyporous confluents. Biosci Biotech Biochem 1992;56:34-41
5. Yoshioka Y, Tabeta R, Saito H, Uehara N, Fukuoka F. Antitumor polysaccharides from P. ostreatus (Fr.) Quel.: isolation and structure of a β-glucan. Carbohydrate Res 1985;140:93-100
6. Mizuno T. A development of antitumor polysaccharides from mushroom fungi. FFI Journal 1996;167:69-85
7. Nakao Y. Curdran: properties and application to foods. Nippon Shokuhin Kogyo Gakkaishi 1991;38:736-742
8. Obayashi T, Tamura H, Tanaka S, Ohki M, Takahashi S, Arai M, Masuda M, Kawai T. A new chromogenetic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Arai 1985;149:55-65
9. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A. Plasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995;345:17-20
10. Obayashi T. Plasma (1→3)-β-D-glucan determination for screening deep mycosis. Infect Immun 1996;44:528-532
11. Aketagawa J, Tamura H, Tanaka S. Chromogenic assay for (1→3)-β-D-glucans using limulus coagulation factor G. J Antibact Antifung Agents 1995;23:413-419
12. Obayashi T, Tamura H, Aketagawa J, Tanaka S, Ohki M, Takahashi S, Kawai T. Determination of plasma (1→3)-β-D-glucan: a new diagnostic aid to deep mycosis. J Med Veter Mycol 1992;30:275-280
13. Yoshida K, Nakajima M, Yamasaki M, Kitano Y, Niki Y, Ohsawa G, Matsushima T. Investigation of the influence of hemodialysis membranes and factors associated with hemodialysis on serum (1→3)-β-D-glucan. Kansenshogaku Zasshi 1998;72:245-248
14. Kanda H, Kubo K, Hamasaki K, Kanda Y, Nakao A, Kitamura T, Fujita T, Yamamoto K, Miura T. Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level. Kidney Int 2001;60:319-323
15. Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A. Elevation of blood (1→3)-β-D-glucan concentrations in hemodialysis patients. Nephron 2001;89:15-19
16. Usami M, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S, Ohata A. Positive (1→3)-β-D-glucan in blood components and release of (1→3)-β-D-glucan from depth-type membrane filters for blood processing. Transfusion 2002;42:1189-1195
17. Klistler P, Nitschmann H. Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Klistler and Lergier. Vox Sang 1962;7:414-424
18. Schneider W, Wolter D, McCarty LJ. Alternatives for plasma fractionation. Vox Sang 1976;31:141-151
19. Cohn EJ, Strong LE, Hughes LE. Preparation and properties of serum and plasma proteins IV. A system for the separation into fractions of the protein and lipoprotein component of biological tissues and fluids. J Am Chem Soc 1946;68:459-475
20. Miura T, Ohno N, Miura N, Shimada S, Yadomae T. Inactivation of a particle β-glucan by proteins in plasma and serum. Biol Pharm Bull 1997;20:1103-1107
21. Olson EJ, Standing JE, Griego-Harper N, Hoffman OA, Limper AH. Fungal β-D-glucan interacts with vitronectin and stimulates tumor necrosis factor alpha release from macrophages. Infect Immun 1996;64:3548-3554
22. Vassallo R, Kotton TJ, Standing JE, Limper AH. Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii. Am J Respir Cell Mol Biol 2001;25:203-211
23. Cerenius L, Liang Z, Duvic B, Keyser P, Hellman US, Sorderhall K. Structure and biological activity of a 1,3-β-D-glucan binding protein in crustacean blood. J Biol Chem 1994;269:29462-29467
24. Osmond RI, Hrmova M, Fontaine F, Imberty A. Binding interactions between barley thaumatin-like proteins and (1,3)-β-glucans. Kinetics, specificity, structural analysis and biological implications. Eur J Biochem 2001;268:4190-4199
25. Ohno N, Miura NN, Nakajima M, Yadomae T. Antitumor 1,3-β-D-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull 2000;23:866-872
26. Lee JN, Lee DY, Ji IH, Kim GE, Kim NH, Sohn J, Kim S, Kim CW. Purification of soluble β-glucan with immune-enhancing activity from the cell wall of yeast. Biosci Biotech Biochem 2001;65:837-841
27. Okazaki M, Adachi Y, Ohno N, Yodomae T. Structure-activity relationship of (1→3)-β-D-glucans in the induction of cytokine production from macrophages, in vitro. Biol Pharm Bull 1995;18:1320-1327
28. Ohno N, Miura NN, Chiba N, Adachi Y, Yadomae T. Comparison of the immunopharmacological activities of triple and single-helical schizophyllan in mice. Biol Pharm Bull 1995;18:1242-1247
29. Hirata N, Tsuzuki A, Ohno N, Saita M, Adachi Y, Yadomae T. Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumor (1→3)-β-D-glucan preparation, sonifilan. Zentralbl Bakteriol 1998;288:403-413
30. Zhuang C, Mizuno T, Ito H, Shimura K. Chemical modification and antitumor activity of polysaccharides from the mycelium of liquid-cultured Grifola frondsa. Nippon Shokuhin Kogyo Gakkaishi 1994;41:733-740
31. Misaki A, Kakuta M, Sasaki T, Tanaka M, Miyaji H. Studies on interrelation of structure and antitumor effects of polysaccharides: antitumor action of periodate-modified, branched (1→3)-glycosidic linkages. Carbohydrate Res 1981;92:115-129
32. Yamada H, Kawaguchi N, Ohmori T, Takeshita Y, Taneya S, Miyazaki T. Structure and antitumor activity of an alkali-soluble polysaccharide from Cordyceps ophioglossoides. Carbohydrate Res 1984;125:107-115
33. Kiho T, Yoshida I, Katsuragawa M, Sakushima M, Usui S, Ukai S. Polysaccharides in fungi. XXXIV. A polysaccharide from the fruiting bodies of Amanita muscaria and the antitumor activity of its carboxymethylated product. Biol Pharm Bull 1994;17:1460-1462